Clinical Case of Atypical Botulism with Pseudointernuclear Ophthalmoplegia Syndrome
- Authors: Kazantsev A.Y.1,2,3, Nikolaeva I.V.1, Khafizova I.F.3,4, Fatkullin B.S.2, Sozinova J.M.2
-
Affiliations:
- Kazan State Medical University
- Republican Clinical Infectious Hospital named by Professor A.F. Agafonov
- Clinical center “Neuroclinic of Professor Yakupov”
- Kazan (Volga Region) Federal University
- Issue: Vol 18, No 3 (2024)
- Pages: 103-108
- Section: Clinical analysis
- URL: https://ogarev-online.ru/2075-5473/article/view/269320
- DOI: https://doi.org/10.17816/ACEN.998
- ID: 269320
Cite item
Abstract
Botulism is a rare cause of bulbar and oculomotor syndromes. A late diagnosis and, therefore, late initiation of specific therapy may lead to multiple life-threatening complications. Epidemiological history and clinical findings are key to the correct diagnosis, but if these data are not available due to atypical clinical findings, botulism identification is challenging.
In our clinical case, a 31-year-old man was admitted to the hospital with double vision, impaired eye movements, and difficulty swallowing rapidly developing for 2 days. Ocular motility dysfunction included disturbed conjugate eye movements. In young patients, this is most often caused by demyelinating disease with medial (posterior) longitudinal fasciculus damage and symmetrical bilateral ptosis. The patient denied eating foods that could cause botulism and did not have any gastrointestinal symptoms. Differential diagnoses included demyelinating disease onset and Miller–Fisher syndrome. The next morning, completely identical clinical signs appeared in the patient’s mother who had eaten canned mushrooms, so botulism was suspected. Over the next few hours, despite the administration of anti-botulinum serum, acute respiratory failure developed, and the patient was placed on a ventilator for 28 days. The patient and his mother were discharged in a satisfactory condition, and their symptoms completely resolved within a few months. The diagnosis of botulism was confirmed by toxicological examination.
Full Text
##article.viewOnOriginalSite##About the authors
Alexander Yu. Kazantsev
Kazan State Medical University; Republican Clinical Infectious Hospital named by Professor A.F. Agafonov; Clinical center “Neuroclinic of Professor Yakupov”
Author for correspondence.
Email: engine90@bk.ru
ORCID iD: 0000-0001-9800-9940
Cand. Sci. (Med.), neurologist, Department of neurology, Kazan State Medical University; neurologist, Republican Clinical Infectious Hospital named by Professor A.F. Agafonov; neurologist, Clinical center “Neuroclinic of Professor Yakupov”
Russian Federation, Kazan; Kazan; KazanIrina V. Nikolaeva
Kazan State Medical University
Email: engine90@bk.ru
ORCID iD: 0000-0003-0104-5895
Dr. Sci. (Med.), Professor, Head, Department of infectious diseases
Russian Federation, KazanIrina F. Khafizova
Clinical center “Neuroclinic of Professor Yakupov”; Kazan (Volga Region) Federal University
Email: engine90@bk.ru
ORCID iD: 0000-0003-2561-7456
Cand. Sci. (Med.), Assoc. Prof., Department of neurology with courses in psychiatry, clinical psychology and medical genetics, Kazan (Volga Region) Federal University; neurologist, Head, Myasthenic Center, Clinical center “Neuroclinic of Professor Yakupov”
Russian Federation, Kazan; KazanBulat Sh. Fatkullin
Republican Clinical Infectious Hospital named by Professor A.F. Agafonov
Email: engine90@bk.ru
ORCID iD: 0009-0004-3505-2166
Cand. Sci. (Med.), Head, Department of intensive care unit No. 1
Russian Federation, KazanJulia M. Sozinova
Republican Clinical Infectious Hospital named by Professor A.F. Agafonov
Email: engine90@bk.ru
ORCID iD: 0009-0000-0126-8808
Cand. Sci. (Med.), Chief, Medical Department
Russian Federation, KazanReferences
- Никифоров В.В., Томилин Ю.Н., Давыдов А.В. и др. Случай тяжелого течения ботулизма: 127 дней искусственной вентиляции легких. Эпидемиология и инфекционные болезни. 2013;18(6):49–57. doi: 10.17816/EID40793 Nikiforov V.V., Tomilin Yu.N., Davydov A.V. et al. The case of severe botulism: artificial ventilation of lungs for 127 days. Epidemiology and Infectious Diseases. 2013;18(6):49–57. doi: 10.17816/EID40793
- Rao A.K., Sobel J., Chatham-Stephens K., Luquez C. Clinical guidelines for diagnosis and treatment of botulism, 2021. MMWR Recomm. Rep. 2021;70(2):1–30. doi: 10.15585/mmwr.rr7002a1
- Rowlands R.E.G., Ristori C.A., Lopes G.I.S.L. et al. Botulism in Brazil, 2000–2008: epidemiology, clinical findings and laboratorial diagnosis. Rev. Inst. Med. Trop. S. Paulo. 2010;52(4):183–186. doi: 10.1590/s0036-46652010000400003
- Lonati D., Schicchi A., Crevani M. et al. Foodborne botulism: clinical diagnosis and medical treatment. Toxins (Basel). 2020;12(8):509. doi: 10.3390/toxins12080509
- Maslanka S.E., Solomon H.M., Sharma S., Johnson E.A. Chapter 32. Clostridium botulinum and its toxins. In: Compendium of methods for the microbiological examination of foods. Washington; 2013.
- Николаева И.В., Гилмуллина Ф.С., Казанцев А.Ю., Фаткуллин Б.Ш. Случай пищевого ботулизма типа F. Эпидемиология и инфекционные болезни. 2022;27(6):360–367. doi: 10.17816/EID120021 Nikolaeva I.V., Gilmullina F.S., Kazantsev A.Yu., Fatkullin B.Sh. A case of foodborne botulism type F. Epidemiology and infectious diseases. 2022;27(6):360–367. doi: 10.17816/EID120021
- Jeremy S., Agam K. R. Making the best of the evidence: toward national clinical guidelines for botulism. Clin. Infect. Dis. 66(suppl_1):S1–S3. doi: 10.1093/cid/cix829
- Jeffery I.A., Karim S. Botulism. Treasure Island; 2023.
- Espelund M., Klaveness D. Botulism outbreaks in natural environments — an update. Front. Microbiol. 2014;5:287. doi: 10.3389/fmicb.2014.00287
- Rao A.K., Lin N.H., Griese S.E. et al. Clinical criteria to trigger suspicion for botulism: an evidence-based tool to facilitate timely recognition of suspected cases during sporadic events and outbreaks. Clin. Infect. Dis. 2017;66(suppl_1):S38–S42. doi: 10.1093/cid/cix814
- Karatas M. Internuclear and supranuclear disorders of eye movements: clinical features and causes. Eur. J. Neurol. 2009;16(12):1265–1277. doi: 10.1111/j.1468-1331.2009.02779.x
- Попелянский Я.Ю. Глазодвижения и взор (паралич, акинез, насильственность). М.; 2004. Popelyansky Ya.Yu. Eye movements and gaze (paralysis, akinesis, violence). Moscow; 2004. (In Russ.)
- Breen L.A. Gaze abnormalities. In: Walsh T.J. (ed.) Neuroophthalmology: clinical signs and symptoms. Philadelphia; 1992.
- Walsh F.B., Hoyt W.F., Miller N.R. Walsh and Hoyts clinical neuro-ophthalmology: the essentials. Philadelphia; 2015.
- Thomke F., Hopf H.C. Abduction paresis with rostral pontine and/or mesencephalic lesions: pseudoabducens palsy and its relation to the so-called posterior internuclear ophthalmoplegia of Lutz. BMC Neurol. 2001;1:4. doi: 10.1186/1471-2377-1-4
- Pierrot-Deseilligny C. The control of gaze (3). Neurological defects. Med. Sci. (Paris). 2004;20(3):357– 362. doi: 10.1051/medsci/2004203357
- Матвеева Т.В. Пропедевтика и семиотика поражений нервной системы в вопросах и ответах. Казань; 2008. Matveeva T.V. Propaedeutics and semiotics of lesions of the nervous system in questions and answers. Kazan; 2008. (In Russ.)
- Клюшников С.А., Азиатская Г.А. Глазодвигательные расстройства в практике невролога. Нервные болезни. 2015;(4):41–47. Klyushnikov S.A., Asiatskaya G.A. Oculomotor disorders in the practice of a neurologist. Nervous diseases. 2015;(4):41–47.
- Nair A.G., Patil-Chhablani P., Venkatramani D.V., Gandhi R.A. Ocular myasthenia gravis: a review. Indian J. Ophthalmol. 2014;62(10):985–991. doi: 10.4103/0301-4738.145987
- Nijsse B., Bettink M.W., Neuteboom R.F. Pseudointernuclear ophthalmoplegia as a presenting feature of ocular myasthenia gravis. BMJ Case Rep. 2014;2014:bcr2013203234. doi: 10.1136/bcr-2013-203234
- McClard C.K., Lyons L.J., Yalamanchili S. Bilateral pseudo-internuclear ophthalmoplegia in a patient with myasthenia gravis. Am. J. Ophthalmol. Case Rep. 2018;12:76–78. doi: 10.1016/j.ajoc.2018.09.008
Supplementary files
